InvestorsHub Logo
Followers 16
Posts 1062
Boards Moderated 0
Alias Born 09/01/2019

Re: None

Wednesday, 07/27/2022 8:58:10 PM

Wednesday, July 27, 2022 8:58:10 PM

Post# of 16699
..

We all bet here in the past. It is still up to continued efforts by the Company towards a strong future and personal decisions of current and new/prospective shareholders.
One developing drug, Ifenprodil for IPF/CC and cancer tumors. Licensed IP and phase 1+ for new paths with microdosed DMT for stroke treatment. . .

COVID authorities in Australia may be open to long term lung care medications for IPF/CC. There are many with long COVID lung symptoms and a supportive Ausie Clinical Trial system.
...GLTA...